Digital PCR And Real-Time PCR (qPCR) Market Is Well-Positioned For Expansion With The Opening Of Ppd’s Clinical Research Laboratory In China To Enhance Research Activities
Recent technological advancements have provided a clear picture of the potential commercial value of digital and real-time PCR technologies. These developments raise many questions about the control, regulation, maintenance, and future of digital and real-time PCR technologies. The recent announcement by the biotechnology industry giants namely Genomics Corp. and Applied DNA Technologies Limited that they have obtained patent rights to certain useful genetic combinations from 23andMe, Illumina, and Kary Mullis are an indication of the expanding scope of digital and real-time PCR technologies. The use of quantitative real-time PCR systems for data analysis and the detection of pathogenicity parameters using qRT-PCR technology has widened the scope of applications beyond laboratory settings. Although, the digital PCR and real-time PCR (qPCR) market growth is projected to be limited by technological restrictions associated with PCR and the high cost of PCR equipment. Recent tech...